Catalyst Wire Dossier Catalyst Wire Dossier

Haploidentical donor natural killer cell infusion with IL-15

haploidentical donor natural killer cells with interleukin-15 · Masonic Cancer Center, University of Minnesota
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Haploidentical donor natural killer cell infusion with IL-15, covering 2025-07-24 to 2025-07-24. Get the full timeline:

Most recent: Clinical Trial Update: Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML) [Phase 1]

See pricing